The company’s keratoconus medication, Epioxa, was effective in a Phase III trial, with plans to file for submission with the ...

Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety between teenagers and adults in an NIH study.

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating ...

Acadia Pharmaceuticals has received marketing authorisation from Health Canada for DAYBUE (trofinetide) to treat Rett ...

Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commercialise sotagliflozin outside the US and ...

The latest round of layoffs will see Sage reduce 33% of its total workforce. Credits: Wirestock Creators/Shutterstock.com ...

Seltorexant is one of J&J’s most promising neuroscience candidates. The human orexin-2 receptor selective agonist produced ...

Lilly’s senior VP of information and R&D IT Ramesh Durvasula said Lilly will use AI and tech to transform the company.

After a hearing held on 25 September 2024, the European Patent Office (EPO) affirmed bit.bio’s claim against an anonymous ...

Radiopharm Theranostics (RAD) and AtomVie have announced a partnership for the development and manufacturing of ...

A new generation of remote monitoring devices in Scotland is helping to reduce the burden on healthcare systems and improve ...

Synedgen has announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to develop ...